| For: | Caballero-Mateos AM, Cañadas-de la Fuente GA. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World J Gastroenterol 2024; 30(35): 3942-3953 [PMID: 39351053 DOI: 10.3748/wjg.v30.i35.3942] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i35/3942.htm |
| Number | Citing Articles |
| 1 |
Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Fabio Leonel Gil-Parada, William Otero-Regino, Jonathan Barreto Perez, German Manuel Tovar Fierro, Fabian Eduardo Puentes-Manosalva, Pedro Eduardo Cuervo Pico, María Teresa Galiano, Javier Riveros, Alvaro Andrés Gomez-Venegas, Carlos Andrés Medrano Almanza, Daniel Perea, Manuel Ballesteros, Carlos Augusto Cuadros Mendoza, Cristian Florez-Sarmiento. Experiencia en mundo real con el uso de upadacitinib en inducción para enfermedad inflamatoria intestinal en Colombia: uparecol-induction. Revista de Gastroenterología del Perú 2025; 45(3) doi: 10.47892/rgp.2025.453.1904
|
| 2 |
Antonio M Caballero-Mateos, Claudio Trigo-Salado, Álvaro Suárez-Toribio, María del Mar Martín-Rodríguez, Francisco J Rodríguez-González, Teresa Valdés-Delgado, Héctor Pallarés-Manrique, Ana María Trapero-Martínez, Raúl Olmedo-Martín, Cristina Bailón-Gaona, José Manuel Benitez Cantero, B Gros, Antonia Sáez-Díaz, Álvaro Hernández-Martínez. Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. World Journal of Gastroenterology 2026; 32(6): 115941 doi: 10.3748/wjg.v32.i6.115941
Abstract(211) |
Core Tip(137) |
Full Article(HTML)(841)
|
Full Article (PDF)-1248K(198)
|
Full Article with Cover (PDF)-1784K(333)
|
Full Article (XML)-90K(45)
|
Audio-1007K(12)
|
Peer-Review Report-310K(57)
|
Answering Reviewers-57K(46)
|
Supplementary Material-53K(39)
|
Times Cited (1)
|
Total Visits (1587)
|
Open
|
| 3 |
Fares A. Qtaishat, Ahmad AlKayyat, Jehad A. Yasin, Mohammad‐Amer A.Tamimi, Jana Tarawneh, Layan AlDaher, Sarah Abdallah, Mohammad Moayad Ahmad Alghaniem, Abdallah Abunamoos, Adham Musa, Yousef A. Ateiwi, Yousef Taha, Tarek A. Tamimi. JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose–Response Network Meta‐Analysis of Efficacy and Safety. JGH Open 2026; 10(3) doi: 10.1002/jgh3.70388
|
| 4 |
Alessia Romano, Giovanna Fernanda Vazzana, Claudio Romano. Pharmacotherapeutic interventions for pediatric ulcerative colitis. Expert Opinion on Pharmacotherapy 2026; 27(11) doi: 10.1080/14656566.2026.2695982
|
| 5 |
Yunze Liu, Yisha Wan, Xinyu Lu, Aili Xu, Xia Ding, Yuan Li. Metabolic reprogramming in ulcerative colitis: integrating dietary drivers, pathogenesis, and therapeutic advances. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1894784
|
| 6 |
Rabeya Jafrin Mow, Xiaodi Shi, Wen Lu, Siming Wang, Didier Merlin, Chunhua Yang. Oral Colon-Targeted Lipid Nanoparticles Enhance Upadacitinib Delivery and Efficacy in a Murine Model of Ulcerative Colitis. International Journal of Molecular Sciences 2026; 27(9) doi: 10.3390/ijms27093758
|
| 7 |
Antonio M. Caballero Mateos, Guillermo A. Cañadas de la Fuente, Beatriz Gros. Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies. Journal of Clinical Medicine 2025; 14(5) doi: 10.3390/jcm14051536
|
| 8 |
Ali Ikram, Farhang Hameed Awlqadr, Mamoona Shehzadi, Azka Irfan, Maneeba khalid, Hamda Noor, Iffat Ullah, Rabbia Khan, Muhammad Tayyab Arshad, Muhammad Husnain, Mohammed Ali Al-Duais, Humaira Parveen, Sayeed Mukhtar, Emmanuel Laryea. Valorisation of garlic peel (Allium sativum L.): a comprehensive review of its nutritional, phytochemical, and therapeutic potential. International Journal of Food Science and Technology 2026; 61(2) doi: 10.1093/ijfood/vvag136
|
| 9 |
Duaa A. Althumairy, Rasha Abu-Khudir, Afnan I. Alandanoosi, Gehan M. Badr. Garlic Peel-Derived Phytochemicals Using GC-MS: Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Effects in Ulcerative Colitis Rat Model. Pharmaceuticals 2025; 18(7) doi: 10.3390/ph18070969
|
| 10 |
Hongkun Li, Yuyue Zhang, Simin Du, Jinghan Shen, Xingyan Liu, Jie Jing. “Remodeling the intestinal immune microenvironment”: immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1543702
|
| 11 |
Aleksandar Radlović, Teodora Safiye, Elvis Mahmutović. The use of corticosteroids in the treatment of ulcerative colitis: A brief overview. Arhiv za farmaciju 2025; 75(3) doi: 10.5937/arhfarm75-57020
|
| 12 |
Muhammad Umar Ahsan, Syeda Laiba Sajid, Rahul Balach, Muhammad Daniyal, Noor Ul Ain, Muhammad Mudasir. Emerging role of Janus kinase inhibitors in ulcerative colitis management. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(4): 110472 doi: 10.4292/wjgpt.v16.i4.110472
|
| 13 |
Antonio M. Caballero-Mateos, Eduard Brunet-Mas, Beatriz Gros. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine 2025; 14(22) doi: 10.3390/jcm14227984
|
| 14 |
Hakim Ullah Wazir, Kartik Mehta, Muhammad Shikaib Shabbir, M. Rafiqul Islam, Muhammad Maaz, Maryam Muzaffar, Nimra Ehsan, Saba Aliha, Anchit Chauhan, Abdul Khurram, George Saffouri. Efficacy and tolerability of janus kinase inhibition strategies for moderate-to-severe Crohn’s disease: A systematic review and bayesian network meta-analysis. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848261485778
|
| 15 |
Genetic Regulation of Immune Response Pathways. Advances in Genetics 2026; 115 doi: 10.1016/bs.adgen.2025.11.008
|
| 16 |
Md. Mizanur Rahaman, Phurpa Wangchuk, Subir Sarker, Qingdong Guan. Targeting Interferon‐Gamma (IFN‐γ)‐Related Signalling Pathways in Inflammatory Bowel Disease: Emerging Inhibitors and Therapeutic Advances. Mediators of Inflammation 2025; 2025(1) doi: 10.1155/mi/3181200
|